Literature DB >> 30952011

Signaling pathway underlying splenocytes activation by polysaccharides from Atractylodis macrocephalae Koidz.

Wei Xu1, Sijia Fang2, Xuemei Cui3, Ran Guan4, Yong Wang5, Fushan Shi6, Songhua Hu7.   

Abstract

Previous study demonstrated that total polysaccharides isolated from Atractylodis macrocephalae Koidz. (RAMPtp) were effective to eliminate intramammary infection in cows. The present study was designed to investigate the immunomodulatory activity of RAMPtp in mouse splenocytes. Splenocyte proliferation, natural killer (NK) cytotoxicity, productions of NO and cytokines, transcription factor activity as well as the signal pathways and receptor were examined. The results showed that RAMPtp significantly promoted splenocyte proliferation and made the cells enter S and G2/M phases, increased ratios of T/B cells, boosted NK cytotoxicity, enhanced transcriptional activities of nuclear factor of activated T cells (NFAT), nuclear factor κB (NF-κB) and activator protein 1 (AP-1), and stimulated secretions of NO, immunoglobulin G (IgG) and multiple cytokine families (IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-6, IL-10, IL-12p40, IL-12p70, IL-13, IFN-γ, TNF-α, G-CSF, GM-CSF, KC, MIP-1α, MIP-1β, RANTES and Eotaxin). In addition, all the specific inhibitors against the mitogen-activated protein kinases (MAPKs) and NF-κB significantly suppressed the IL-6 production induced by RAMPtp. Moreover, splenocytes from Toll-like receptor 4 (TLR4) deficient mouse responded equally to RAMPtp stimulation as the wild-type. Therefore, RAMPtp might induce splenocytes activation at least in part via the TLR4-independent MAPKs and NF-κB signaling pathways. The present results would be useful to further understand the immunomodulatory mechanisms of RAMPtp in elimination of intramammary infection in cows.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Atractylodis macrocephalae Koidz.; Immunomodulaton; Lymphocytes; Polysaccharides; Signaling pathway

Mesh:

Substances:

Year:  2019        PMID: 30952011     DOI: 10.1016/j.molimm.2019.03.004

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  6 in total

1.  Effects of PAMK on lncRNA, miRNA, and mRNA expression profiles of thymic epithelial cells.

Authors:  Qingru Wu; Bingxin Li; Ying Li; Fenfen Liu; Lin Yang; Yongjiang Ma; Yuan Zhang; Danning Xu; Yugu Li
Journal:  Funct Integr Genomics       Date:  2022-05-04       Impact factor: 3.674

2.  Ginseng Stem-Leaf Saponins in Combination with Selenium Promote the Immune Response in Neonatal Mice with Maternal Antibody.

Authors:  Yong Wang; Lijia Yuan; Xuemei Cui; Wei Xu; Sijia Fang; Zoushuyi Li; Meiqian Lu; Ye Wu; Xiaodan Ma; Xiaoqing Chi; Songhua Hu
Journal:  Vaccines (Basel)       Date:  2020-12-11

3.  Relationship Between the Structure and Immune Activity of Components From the Active Polysaccharides APS-II of Astragali Radix by Enzymolysis of Endo α-1,4-Glucanase.

Authors:  Ke Li; Xue-Qin Li; Guang-Xin Li; Lian-Jie Cui; Xue-Mei Qin; Zhen-Yu Li; Yu-Guang Du; Yue-Tao Liu; Ai-Ping Li; Xing-Yun Zhao; Xin-Hui Fan
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810

4.  Assembly encapsulation of BSA and CCCH-ZAP in the sodium alginate/atractylodis macrocephalae system.

Authors:  Shuxin Zhang; Hai Fan; Chunrong Yi; Ying Li; Kunmei Yang; Shenglong Liu; Ziqiang Cheng; Jianchao Sun
Journal:  RSC Adv       Date:  2022-04-26       Impact factor: 3.361

Review 5.  Polysaccharides from Rhizoma Atractylodis Macrocephalae: A Review on Their Extraction, Purification, Structure, and Bioactivities.

Authors:  Lei Luo; Jin Cai; Zhang Zhou; Wenqian Tang; Juan Xue; Jinxin Liu; Hongfei Hu; Fan Yang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-17       Impact factor: 2.650

6.  Immune-Enhancing Activity of Aqueous Extracts from Artemisia rupestris L. via MAPK and NF-kB Pathways of TLR4/TLR2 Downstream in Dendritic Cells.

Authors:  Yu Yang; DanYang Wang; QuanXiao Li; Jiang He; Bin Wang; Jinyao Li; Ailian Zhang
Journal:  Vaccines (Basel)       Date:  2020-09-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.